Arcutis Biotherapeutics Inc Capital Reinvestment Ratio

Latest as of June 2026: 0.01x

Arcutis Biotherapeutics Inc capital reinvestment ratio. Arcutis Biotherapeutics Inc (ARQT) has a Capital Reinvestment Ratio of 0.01x as of June 2026, meaning it reinvests 0% of its operating cash flow ($12.64 Million) in capital expenditures ($158.00K). See cash generation quality of Arcutis Biotherapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

$12.64 Million

USD

Capital Expenditures

$158.00K

USD

Data as of

Jun 2026

Most recent filing

Arcutis Biotherapeutics Inc Capital Reinvestment Ratio by Year (None–None)

Arcutis Biotherapeutics Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Arcutis Biotherapeutics Inc (ARQT) cash flow conversion.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow